News
NEW HAVEN, Conn., July 8, 2025 /PRNewswire/ -- Yale School of Medicine (YSM) was awarded a $27.7 million grant from Aligning ...
The CHFA Board of Directors serves as the governing body, vested with full statutory authority to set policies, appoint ...
23h
NBC4 WCMH-TV on MSNHow horses are helping children overcome speech, language disordersChildren with speech and language difficulties worked with horses in a first-ever pilot camp using evidence-based equine therapy. Some may not realize the impact that ...
Nagpur: The Nagpur Municipal Corporation (NMC) has launched the final phase of its comprehensive citywide survey to collect ...
As the Americans with Disabilities Act turns 35 this month, states are conducting surveys to better understand the ...
Background The burden of cardiovascular events in Africa is projected to rise significantly in the coming decade, placing ...
A research team led by Prof. Li Hai from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has ...
1d
News-Medical.Net on MSNSlower speech response linked to sleepiness in older adultsA new study led by UCLA investigators shows that Verbal Reaction Time (VRT), the amount of time it takes a person to respond ...
A Comparative Study of AI-Powered Chatbot for Health Care. Journal of Computer and Communications, 13, 48-66. doi: 10.4236/jcc.2025.137003 . The need for this research arises from the increasing ...
The interaction between speech perception and the brain's cortical activity remains an important area of study in neuroscience. Speech perception, an ...
As with so many calls previously about 9-year-old Delilah, Kelli Stanley braced for more uncertainty. But this time was different. This time, they finally had a name.
A phase 3 trial of Tocagen’s therapy for high-grade glioma (HGG) – a form of brain cancer – failed to show an improvement in overall survival, sending the biotech’s shares into freefall.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results